MD Start
VC Fund
Paris, France
MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries MD Start invests in
Stages MD Start invests in
Countries MD Start invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Investment Focus
Industry
- Medical Device 3 (75%)
- Health Care 2 (50%)
- Medical 1 (25%)
- Biotechnology 1 (25%)
Stage
- Seed 3 (75%)
- Series B 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gerard Hascoet
Executive Chairman
|
Executive Chairman | Total investments: 4 | Find email | |
|
Anne Osdoit
Partner
|
Partner | Total investments: 7 | Find email | |
|
Tim Lenihan
Partner / Entrepreneur In Residence
|
Partner / Entrepreneur In Residence | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. | $55.4M / Series B / May 17, 2023 | |
|
|
MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. | $3.4M / Seed / Jul 02, 2020 | |
|
|
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University. | Seed / Feb 01, 2020 | |
|
|
HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation. | Seed / Jun 01, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does MD Start invest in?
MD Start invests primarily in Medical Device, Health Care and Medical startups, most often at Seed and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact MD Start?
Public channels for MD Start include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MD Start?
The team at MD Start includes Gerard Hascoet (Executive Chairman), Anne Osdoit (Partner) and Tim Lenihan (Partner / Entrepreneur In Residence). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!